Background: Despite increasing emphasis on using multiple methods to assess personality constructs in psychosomatic research, previous investigations of relations between alexithymia and type A behavior (TAB) have been limited by the use of single methods of measurement and almost no attempt to assess subcomponents of TAB. The aims of this study were to (1) evaluate levels of agreement between structured interview assessments of alexithymia, TAB, hostility, and time urgency and well-established self-report measures of these constructs, and (2) explore relations between alexithymia and TAB and its subcomponents in patients with coronary heart disease (CHD). Methods: 62 CHD patients were investigated 6 weeks after coronary angioplasty. Alexithymia was assessed with the Diagnostic Criteria for Psychosomatic Research (DCPR) and the 20-item Toronto Alexithymia Scale (TAS-20). TAB was assessed with the DCPR and the Short Form of the Jenkins Activity Survey Type A scale (JAS-SF). Time urgency was assessed with the DCPR and the Speed/Impatience scale of the Jenkins Activity Survey (JAS-S), and hostility was assessed with the DCPR and the Hostility subscale of the Revised Symptom Checklist-90 (SCL-HOS). Results: The DCPR classifications showed reasonably high levels of agreement with the TAS-20 and JAS-SF classifications of alexithymia and TAB, but lower levels of agreement in identifying patients with high hostility on the SCL-HOS and high time urgency on the JAS-S. Alexithymia measured by both the DCPR and the TAS-20 was unrelated to both self-report and structured interview measures of TAB, hostility, and time urgency. Conclusions: The DCPR is a suitable screening instrument for assessing alexithymia and TAB, although the two constructs are unrelated.

1.
Kazdin AE: Research Design in Clinical Psychology, ed 2. New York, Allyn & Bacon, 1992.
2.
Beresnevaité M: Exploring the benefits of group psychotherapy in reducing alexithymia in coronary heart disease patients: a preliminary study. Psychother Psychosom 2000;69:117–122.
3.
Valkamo M, Hintikka J, Honkalampi K, Niskanen L, Koivumaa-Honkanen H, Viinamäki H: Alexithymia in patients with coronary heart disease. J Psychosom Res 2001;50:125–130.
4.
Valkamo M, Hintikka J, Niskanen L, Viinamäki H: Psychiatric comorbidity and the presence and absence of angiographic coronary disease in patients with chest pain. Acta Psychiatr Scand 2001;104:391–396.
5.
Numata Y, Ogata Y, Oike Y, Matsumura T, Shimada K: A psychobehavioral factor, alexithymia, is related to coronary spasm. Jpn Circ J 1998;62:409–413.
6.
Grandi S, Fabbri S, Tossani E, Mangelli L, Branzi A, Magelli C: Psychological evaluation after cardiac transplantation: the integration of different criteria. Psychother Psychosom 2001;70:176–183.
7.
Rafanelli C, Roncuzzi R, Finos L, Tossani E, Tomba E, Mangelli L, Urbinati S, Pinelli G, Fava GA: Psychological assessment in cardiac rehabilitation. Psychother Psychosom 2003;72:343–349.
8.
Thoreson CE, Powell LH: Type A behavior pattern: new perspectives on theory, assessment, and intervention. J Consult Clin Psychol 1992;60:595–604.
9.
Rosenman RH: The interview method of assessment of the coronary-prone behavior pattern; in Dembroski TM, Weiss SM, Shields JL, Haynes SG, Feinleib M (eds): Coronary-Prone Behavior. New York, Springer, 1978, pp 55–70.
10.
Jenkins CD, Zyzanski SJ, Rosenman RH: Jenkins Activity Survey Manual. The Psychological Corporation. New York, Harcourt Brace Jovanovich, 1979.
11.
Dembroski TM, Czajkowski SM: Historical and current developments in coronary-prone behavior; in Siegman AW, Dembroski TM (eds): In Search of Coronary-Prone Behavior: Beyond Type A. Hillsdale, Erlbaum, 1989, pp 21–39.
12.
Cole SR, Kawachi I, Liu S, Gaziano JM, Manson JE, Buring JE, Hennekens CH: Time urgency and risk of non-fatal myocardial infarction. Int J Epidemiol 2001;30:363–369.
13.
Dembroski TM, Costa PT: Coronary prone behavior: components of the type A pattern and hostility. J Pers 1987;55:211–235.
14.
Miller TQ, Smith TW, Turner CW, Guijarro ML, Hallett AJ: A meta-analytic review of research on hostility and physical health. Psychol Bull 1996;119:322–348.
15.
Jorgensen RS, Frankowski JJ, Lantinga LJ, Phadke K, Sprafkin RP, Abdul-Karim KW: Defensive hostility and coronary heart disease: a preliminary investigation of male veterans. Psychosom Med 2001;63:463–469.
16.
Boyle SH, Williams RB, Mark DB, Brummett BH, Siegler IC, Helms MJ, Barefoot JC: Hostility as a predictor of survival in patients with coronary artery disease. Psychosom Med 2004;66:629–632.
17.
Dembroski TM, MacDougall JM, Costa PT, Grandits GA: Components of hostility as predictors of sudden death and myocardial infarction in the multiple risk factor intervention trial. Psychosom Med 1989;51:514–522.
18.
Siegman AW, Townsend ST, Civelek AC, Blumenthal RS: Antagonistic behavior, dominance, hostility, and coronary heart disease. Psychosom Med 2000;62:248–257.
19.
Donker FJS, Breteler MHM, van der Staak CPF: Assessment of hostility in patients with coronary heart disease. J Pers Assess 2000;75:158–177.
20.
Ottolini F, Modena MG, Rigatelli M: Prodromal symptoms in myocardial infarction. Psychother Psychosom 2005;74:323–327.
21.
Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63:1–8.
22.
Mangelli L, Rafanelli C, Porcelli P, Fava GA: Interview for the Diagnostic Criteria for Psychosomatic Research (DCPR). Psychother Psychosom 2003;72:346–348.
23.
Porcelli P, De Carne, Fava GA: Assessing somatization in functional gastrointestinal disorders: integration of different criteria. Psychother Psychosom 2000;69:198–204.
24.
Grassi L, Sabato S, Rossi E, Biancosino B, Marmai L: Use of the diagnostic criteria for psychosomatic research in oncology. Psychother Psychosom 2005;74:100–107.
25.
Bagby RM, Parker JDA, Taylor GJ: The twenty-item Toronto Alexithymia Scale. I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38:23–32.
26.
Bagby RM, Taylor GJ, Parker JDA: The twenty-item Toronto Alexithymia Scale. II. Convergent, discriminant, and concurrent validity. J Psychosom Res 1994;38:33–40.
27.
Taylor GJ, Bagby RM, Parker JDA: The 20-item Toronto Alexithymia Scale. IV. Reliability and factorial validity in different languages and cultures. J Psychosom Res 2003;55:277–283.
28.
Taylor GJ, Bagby RM, Parker JDA: Disorders of Affect Regulation. Alexithymia in Medical and Psychiatric Illness. Cambridge, Cambridge University Press, 1997.
29.
Beresnevaite M, Taylor GJ, Parker JDA, Andziulis A: Cross validation of the factor structure of a Lithuanian translation of the 20-item Toronto Alexithymia Scale. Acta Med Lithuanica 1998;5:146–149.
30.
Glazunov IS, Dowd JE, Baubiniene A, Grabauskas V, Sturmans F, Schuurman JH: The Kaunas Rotterdam Intervention Study. Amsterdam, Elsevier, 1981.
31.
Goštautas A, Perminas A: Psichologiniu (elgesinių) asmens ypatybių ryšyš su miokardo infarktu ‘KRIS’ programoje (20 metų stebejimo duomenys). [Relation between the psychological (behavioral) peculiarities of personality and myocardial infarction in the KRIS 20-year follow-up.] Medicina 1997;33:50–57.
32.
Goštautas A, Perminas A, Vilkauskas L: Stresogeninio elgesio (A tipo) itaka sergamumui miokardo infarktu ir mirtingumui (25 metų stebejimo duomenys). [Impact of stressogenic behavior (type A behavior) on mortality and MI morbidity as evidenced by a 25-year follow-up.] Lithuanian J Cardiol 1999;6:278–285.
33.
Perminas A: Psichologinių elgsenos veiksnių ryšys su miokardo infarkto išsivystymu ir mirtimi tarp vidutinio amžiaus vyrų 25 metų stebėjimo duomenimis. Daktaro disertacija. [Relationship between Psychological Behavioral Factors and Myocardial Infarction and Death in Middle-Aged Men in 25 Years Follow-Up Period, doctoral diss.]. Kaunas, Lithuania, 1999.
34.
Derogatis LR: SCL-90R: Administration, Scoring and Procedures Manual-II. Baltimore, Clinical Psychometric Research, 1992.
35.
Porcelli P, De Carne M: Criterion-related validity of the diagnostic criteria for psychosomatic research for alexithymia in patients with functional gastrointestinal disorders. Psychother Psychosom 2001;70:184–188.
36.
Bagby RM, Taylor GJ, Parker JDA, Dickens SE: The development of the Toronto Structured Interview for Alexithymia: item selection, factor structure, reliability and concurrent validity. Psychother Psychosom 2006;75:25–39.
37.
Matthews KA: Coronary heart disease and type A behaviors: update on and alternative to the Booth-Kewley and Friedman (1987) quantitative review. Psychol Bull 1988;104:373–380.
38.
Gallacher JEJ, Sweetnam PM, Yarnell JWG, Elwood PC, Stansfeld SA: Is type A behavior really a trigger for coronary heart disease events? Psychosom Med 2003;65:339–346.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.